期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 24, 期 23, 页码 -出版社
MDPI
DOI: 10.3390/ijms242316728
关键词
endocannabinoid system; CB1 receptors; CB2 receptors; stroke recovery; neuroinflammation; immunomodulation; CIDS
The endocannabinoid system offers a promising avenue for therapeutic interventions, but the presence of cannabinoid receptors in various organs and tissues can complicate targeted treatments. Injuries to the central nervous system can induce neuroinflammation and potentially affect the immune system. Exploring immunomodulatory therapies provides a hopeful alternative in the face of challenges in traditional preventive treatments.
The endocannabinoid system, with its intricate presence in numerous cells, tissues, and organs, offers a compelling avenue for therapeutic interventions. Central to this system are the cannabinoid receptors 1 and 2 (CB1R and CB2R), whose ubiquity can introduce complexities in targeted treatments due to their wide-ranging physiological influence. Injuries to the central nervous system (CNS), including strokes and traumatic brain injuries, induce localized pro-inflammatory immune responses, termed neuroinflammation. Research has shown that compensatory immunodepression usually follows, and these mechanisms might influence immunity, potentially affecting infection risks in patients. As traditional preventive treatments like antibiotics face challenges, the exploration of immunomodulatory therapies offers a promising alternative. This review delves into the potential neuroprotective roles of the cannabinoid receptors: CB1R's involvement in mitigating excitotoxicity and CB2R's dual role in promoting cell survival and anti-inflammatory responses. However, the potential of cannabinoids to reduce neuroinflammation must be weighed against the risk of exacerbating immunodepression. Though the endocannabinoid system promises numerous therapeutic benefits, understanding its multifaceted signaling mechanisms and outcomes remains a challenge.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据